Michael Zinda

Track

Insider profile

Currently holds a position at Repare Therapeutics Inc

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 10% 68% 82%
Transactions
16 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President, Chief Scientific Officer Repare Therapeutics Inc May 1, 2019 -
Executive Vice President, Head of R&D Repare Therapeutics Inc None -
Michael Zinda's trades of Repare Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-14 2025-03-12
S Sale
38,172 -39.9%
235.33
US$4,109,227 		38,172 -39.9% 235.33 US$4,109,227
2024-04-01 2024-04-01
PlS Planned sale
91,911 +35.3%
440.90
US$2,897,007 		91,911 +35.3% 440.90 US$2,897,007
2024-04-01 2024-03-28
PlS Planned sale
58,300 +16.6%
406.59
US$4,844,566 		58,300 +16.6% 406.59 US$4,844,566
2024-03-27 2024-03-27
PlS Planned sale
450 -0.6%
4.62
US$2,079 		450 -0.6% 4.62 US$2,079
2024-03-27 2024-03-26
PlS Planned sale
450 -0.6%
4.61
US$2,074 		450 -0.6% 4.61 US$2,074
2024-03-27 2024-03-25
PlS Planned sale
450 -0.6%
4.78
US$2,151 		450 -0.6% 4.78 US$2,151
2024-03-25 2024-03-25
PrS Proposed sale
2,210
4.89
US$10,807 		2,210 4.89 US$10,807
2023-06-09 2023-06-07
PlS Planned sale
6,404 -9.2%
12.03
US$77,040 		6,404 -9.2% 12.03 US$77,040
2023-06-07 2023-06-06
PlS Planned sale
1,200 -1.7%
12.04
US$14,448 		1,200 -1.7% 12.04 US$14,448
2023-06-06 2023-06-06
PrS Proposed sale
10,473
11.75
US$123,058 		10,473 11.75 US$123,058
2022-03-16 2022-03-15
PlS Planned sale
533 -1.1%
11.30
US$6,023 		533 -1.1% 11.30 US$6,023
2021-11-17 2021-11-15
PlS Planned sale
3,900 -88.0%
27.87
US$108,693 		3,900 -88.0% 27.87 US$108,693
2021-11-17 2021-11-15
PlS Planned sale
16,100 -78.4%
27.20
US$437,920 		16,100 -78.4% 27.20 US$437,920
2021-05-18 2021-05-17
PlS Planned sale
1,829 -4.9%
33.07
US$60,493 		1,829 -4.9% 33.07 US$60,493
2021-05-18 2021-05-17
PlS Planned sale
12,439 -25.0%
32.72
US$407,053 		12,439 -25.0% 32.72 US$407,053
2021-05-18 2021-05-17
PlS Planned sale
732 -1.4%
31.65
US$23,165 		732 -1.4% 31.65 US$23,165
2020-12-30 2020-12-29
S Sale
950 -1.8%
35.01
US$33,260 		950 -1.8% 35.01 US$33,260
2020-12-30 2020-12-29
S Sale
4,207 -7.6%
34.63
US$145,688 		4,207 -7.6% 34.63 US$145,688
2020-12-30 2020-12-29
S Sale
14,539 -20.7%
33.30
US$484,149 		14,539 -20.7% 33.30 US$484,149
2020-12-30 2020-12-28
S Sale
322 -0.5%
34.60
US$11,141 		322 -0.5% 34.60 US$11,141
2020-12-30 2020-12-28
S Sale
14,726 -17.3%
34.24
US$504,218 		14,726 -17.3% 34.24 US$504,218
2020-12-28 2020-12-24
S Sale
432 -0.5%
33.14
US$14,316 		432 -0.5% 33.14 US$14,316
2020-12-28 2020-12-23
S Sale
3,679 -4.1%
34.26
US$126,043 		3,679 -4.1% 34.26 US$126,043
2020-12-28 2020-12-23
S Sale
12,556 -12.4%
33.48
US$420,375 		12,556 -12.4% 33.48 US$420,375
2020-12-28 2020-12-22
S Sale
39,700 -31.8%
33.36
US$1,324,392 		39,700 -31.8% 33.36 US$1,324,392
2020-12-28 2020-12-22
S Sale
1,612 -1.3%
34.00
US$54,808 		1,612 -1.3% 34.00 US$54,808
2020-12-22 2020-12-21
S Sale
40,000 -31.9%
33.08
US$1,323,200 		40,000 -31.9% 33.08 US$1,323,200
2020-12-18 2020-12-18
S Sale
200 -0.2%
35.10
US$7,020 		200 -0.2% 35.10 US$7,020
2020-12-18 2020-12-18
S Sale
8,121 -8.7%
34.59
US$280,905 		8,121 -8.7% 34.59 US$280,905
2020-12-18 2020-12-16
S Sale
934 -1.1%
36.01
US$33,633 		934 -1.1% 36.01 US$33,633
2020-12-18 2020-12-16
S Sale
8,022 -8.5%
35.17
US$282,134 		8,022 -8.5% 35.17 US$282,134